City of #SanFrancisco is buzzing w/ excitement of new #HealthTech tomorrow starts w/ panel at #BiotechShowcase Demy Colton Neurodegenerative Disease Modality.AI AquaPartner Beth Hoffman Origami Therapeutics, Inc. Altoida, Inc. Mickey D Cognito Therapeutics - BioWorld Stanford Neurology & Neurological Sciences Nature Neuroscience

Our CEO, Beth J Hoffman kicks off #BiotechShowcase2024

Our CEO, Travis Stiles, will be at the #JPM2024 meeting in San Francisco this week. If you're also attending this event & would like to organize a time to chat about our work on #remyelination, #spinalcordinjury or #tauopathies, please get in touch & we'll happily arrange a time.

Key words I heard this #JPM24 week: ADCs, radiopharmaceuticals, obesity, neuro, return to fundamentals, pipeline vs. platform. Could be a crossword puzzle…. Ron Leuty put it best: it’s the year of the 3 letter acronyms: IPO, M&A, IRA, FTC, BTD. 😂😂

Good morning from Palm Springs, California, where the HDBuzz team will be live-tweeting scientific talks at the 19th HD Therapeutics Conference, hosted by the HD research foundation CHDI. #HDTC2024

Our CEO, Beth J Hoffman , will be sharing her views on the use of 3D tissue models in a regulatory context at the upcoming 9th Annual 3D Tissue Model Conference in Boston ter.li/ivpgnl

March 11th - 17th, is #BrainAwarenessWeek2024. BAW is an annual awareness initiative to support the 1 in 3 people who will experience a neurological condition in their lifetime. As a member of Neurological Alliance of Ireland, HDAI is proud to participate. #LoveYourBrain

Celebrating the legacy of Nancy Wexler, who led a team of scientists to discover the #Huntingtonsdisease gene, the basis for today's #HD research. Nancy has helped women flourish in the field of HD research. #IWD2024 #InspireInclusion @HDYOeed HDSA HDBuzz The American Brain Coalition

Tune in to a webinar hosted by the Hereditary Disease Foundation, HDF, that features HDBuzz's own Jeff, Rachel, and Tam!

After “terrific” conference, CHDI Foundation head scientist declares that #HuntingtonsDisease community will “get there” in search for therapies. #CureHDNow Pope Leo XIV President Donald J. Trump HDSA Help4HD Roche PTC Therapeutics uniQure Vertex Pharmaceuticals NIH @NYTimes STAT curehd.blogspot.com/2024/03/huntin…

Our CEO Beth J Hoffman answers questions about our company as a finalist at the #bio2024 Start-Up Stadium.

Our CFO Karen Harris is speaking on a #BIF2024 panel today at 11 AM PT titled "Expansion of Neurodegenerative Disease Targets and Pipelines." The panel will cover momentum in #neurodegenerative disease research & the future of its #investment landscape: bit.ly/3NrhlA3

Our CEO, Beth J Hoffman , participated in a very successful panel on the progress being made in developing new therapeutics for neurodegenerative disease at the BIO Investor Forum #BIF2024. bio.news/bio-convention…

Congratulations to Sarah Tabrizi for her election into National Academy of Medicine "for contributions that have impacted experimental therapeutics of #Huntingtonsdisease..." tinyurl.com/NAM-Tabrizi #curehd #community HDYO The American Brain Coalition HDSA Huntington's Disease Association HDBuzz UCL Huntington’s Disease Centre UCL Queen Square Institute of Neurology

We are pleased to announce that our CEO, Beth J Hoffman will be speaking at the 2nd Protein Degradation for CNS Summit, running February 18-20 in Boston! You can find information about her session and the forum by downloading the full event guide here: ter.li/pwny7z

Great to see Origami included in this list of disease-modifying approaches to HD.

Our CEO, Beth J Hoffman is joining an outstanding line up of speakers at the 2nd Protein Degradation for CNS Summit. Find out more here: ter.li/0zyud4

Nice mention of Origami in Labiotech listing top companies innovating in the ALS space. labiotech.eu/best-biotech/a…

Excited to have been selected one of the StartUp Stadium Finalists at #BIO2025. If you are attending, come see our CEO, Beth J Hoffman present on Monday, June 16 at 2:45 pm. convention.bio.org/program-1/star…

Our CEO Beth J Hoffman had the pleasure of participating in an engaging panel discussing Next Generation Alzheimer’s Disease Therapies at #bio2025.